PB Fintech to Attend Citi's 2026 Pan-Asia Conference on May 19-20 in Singapore

PB Fintech Limited has notified the stock exchanges of its management's scheduled participation in an upcoming investor conference, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation, dated May 07, 2026, was filed by Company Secretary and Compliance Officer Bhasker Joshi.

Conference Details

The management of PB Fintech will attend Citi's 2026 Pan-Asia Conference as a physical event held in Singapore. The following table outlines the key details of the scheduled interaction:

Parameter:	Details
Date of Meeting:	May 19-20, 2026
Event:	Citi's 2026 Pan-Asia Conference
Mode:	Physical
Location:	Singapore
Time:	09:00 AM (SG Time)

Regulatory Compliance and Disclosures

The intimation has been filed pursuant to Regulation 30, read with Schedule III and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, along with corresponding circulars and notifications issued thereunder. The company has explicitly stated that no unpublished price sensitive information will be shared during the interaction. PB Fintech has also noted that the above schedule is subject to change due to exigencies on the part of the company or investors. The disclosure is available on the company's website at https://www.pbfintech.in/investor-relations .

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-2.32%	-1.27%	+12.70%	-7.78%	+0.30%	+36.83%

PB Fintech Limited has submitted the Monitoring Agency Report for the quarter ended March 31, 2026, confirming no deviation in the utilization of IPO proceeds. Issued by ICICI Bank Limited, the report verifies that the funds have been applied strictly in accordance with the objects stated in the Offer Document. The disclosure, signed by Company Secretary and Compliance Officer Bhasker Joshi, was reviewed by the Audit Committee on May 06, 2026.

IPO Fund Raising Details

The company raised funds through a public issue that opened on November 1, 2021, and closed on November 3, 2021. Trading approval was received from NSE and BSE on November 12, 2021. The total issue size was INR 57,097.15 million, comprising a fresh issue and an offer for sale.

Parameter	Details
Mode of Fund Raising	Public Issue
Date of Raising Funds	November 15, 2021
Total Issue Amount	INR 57,097.15 Million
Fresh Issue Amount	INR 37,500.00 Million
Offer for Sale Amount	INR 19,597.15 Million
Monitoring Agency	ICICI Bank Limited
Quarter Reported	March 31, 2026
Deviation / Variation	No

Object-wise Utilisation of Funds

The following table details the object-wise utilisation of the fresh issue proceeds (net of offer expenses) as at the end of the quarter ended March 31, 2026. The total revised allocation for the fresh issue stood at INR 36,126.85 million, which has been fully utilized.

Object	Original Allocation (INR Million)	Revised Allocation (INR Million)	Funds Utilized (INR Million)
Enhancing visibility and awareness of brands	15,000.00	15,000.00	15,000.00
New opportunities to expand growth initiatives	3,750.00	7,985.19	7,985.19
Funding Strategic investments and acquisitions	6,000.00	4,264.81	4,264.81
Expanding presence outside India	3,750.00	1,250.00	1,250.00
General corporate purposes	7,630.90	7,626.85	7,626.85
Total	36,130.90	36,126.85	36,126.85

Key Utilisation Notes

During the quarter ended March 31, 2026, the company utilized INR 1,902.04 million and INR 0.03 million through its subsidiaries Policybazaar Insurance Brokers Private Limited and Paisabazaar Marketing and Consulting Private Limited, respectively. Additionally, an overseas investment of INR 309.21 million was made in equity shares of M/s Genesis Group Limited via its wholly-owned subsidiary Icall Support Services Private Limited to support expansion outside India.

Modifications to the original allocations were approved by shareholders via special resolution on March 16, 2025. These included redirecting unutilized proceeds from strategic investments and international expansion towards new growth initiatives. The timeline for utilizing these funds was extended until March 31, 2026. The Monitoring Agency confirmed that all statutory approvals were obtained and no material deviations were observed.